IKZF1 and Miyoshi myopathy: As treatment of MM with IMiDs leads to ubiquitylation and proteasomal degradation of IKZF1 and IKZF3, and this results in transcriptional suppression of MYC,14,38 it makes intuitive sense to rationally identify other targeted approaches involving MYC downregulation that have synergizing potential.